BIONTECH SE-ADR (BNTX) Stock News
NASDAQ:BNTX - Nasdaq - US09075V1026 - ADR - Currency: USD
BNTX Latest News, Press Relases and Analysis
4 Pipeline Stocks to Buy With $1,000 and Hold Forever
Pipeline companies remain well positioned despite the current disruption in the energy markets. At the same time, demand for natural gas is growing. This is coming from the increased power consumption stemming from artificial intelligence (AI), as well as from export demand from Mexico and for LNG (liquified natural gas) to Asia and Europe.
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today
Mentions: SMMT
BioNTech präsentiert auf der AACR-Jahrestagung 2025 klinische und präklinische Daten zu mRNA- und Immunonkologie-Fokus-Programmen
MAINZ, Deutschland, 24. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der diesjährigen Jahrestagung...
BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025
MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified...
BioNTech Surges On Summit's Coattails. But Can They Take On Merck?
BioNTech is on the rise after Summit Therapeutics unveiled promising results for its PD-1- and VEGF-blocking drug.
This Company's Co-CEOs Just Bought More Shares. Should You?
Nobody has more information about a company than its insiders, especially its executive management team. On April 8, Summit Therapeutics' co-CEOs, Robert Duggan and Maky Zanganeh, each exercised warrants, financial instruments that grant their holders the right (but not the obligation) to acquire a company's shares at a predetermined price before a particular date. Do Summit Therapeutics' prospects -- beyond this recent development -- justify investing in the stock today?
BioNTech veröffentlicht am 5. Mai 2025 Ergebnisse für das erste Quartal 2025 und informiert über operativen Fortschritt
MAINZ, Deutschland, 22. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird am Montag, den 5. Mai 2025, die...
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
MAINZ, Germany, April 22, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the...
BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
Novavax Retail Traders Rally In Defense After RFK Jr.'s COVID-19 Vaccine Skepticism Sends Stock Tumbling
Kennedy singled out the Novavax COVID-19 shot's single-antigen composition as the reason behind the delay in granting full approval.
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care.
Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where BioNTech SE (NASDAQ:BNTX) stands against other best German stocks to buy according to hedge funds. Germany’s economy is facing continued weakness. According to a report published by […]
Is Deutsche Bank Aktiengesellschaft (DB) the Best German Stock to Buy According to Hedge Funds?
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Deutsche Bank Aktiengesellschaft (NYSE:DB) stands against other best German stocks to buy according to hedge funds. Germany’s economy is facing continued weakness. According to a report published […]
Is Quanta Services Inc. (PWR) the Best Engineering Stock to Invest in Now?
We recently published a list of 11 Best Engineering Stocks to Invest in Now. In this article, we are going to take a look at where Quanta Services Inc. (NYSE:PWR) stands against other best engineering stocks to invest in now. The global engineering services market was valued at $3.26 trillion in 2023, as reported by […]
Vaccine Makers Plunge After FDA Biologics Head Marks Steps Down
Moderna Inc. shares plunged after the resignation of Peter Marks, a top regulator at the US Food and Drug Administration who had long overseen approvals of vaccines and other biological drugs.
BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic
For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros.
BioNTech Se (BNTX) Q4 2024 Earnings Call Transcript
BNTX earnings call for the period ending December 31, 2024.
BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 sowie Informationen zur Geschäftsentwicklung
Onkologie-Pipeline weiterentwickelt mit mehr als 20 aktiven klinischen Phase-2- und Phase-3-Studien mit strategischem Fokus auf zwei tumorübergreifende...
BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor programs:...
BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
Why Moderna Stock Has Surged 20% This Week Despite Mixed News
Recent news has been mixed with a patent win and loss in Germany and the U.S. But Moderna stock has risen markedly this week.